Pro Dex Financial Results
Pro-Dex, Inc. reported its fiscal 2027 first quarter results, with net sales increasing 11% to $20.6 million driven by medical device revenue growth. Net income decreased to $3.0 million from $4.7 million in the prior year, primarily due to a significant decrease in unrealized gains on marketable equity investments compared to the year-ago period.
- Term
- Q1 2027
“We are pleased with our first quarter results and continued top line revenue growth.”
Richard L. (“Rick”) Van Kirk, the Company’s President and Chief Executive Officer
“We are also pleased to be working with the Monogram and Zimmer Biomet teams and expect to ship validation units later this fiscal year.”
Richard L. (“Rick”) Van Kirk, the Company’s President and Chief Executive Officer